1KZV - Header Asymmetric Unit

HEADER VIRAL PROTEIN 08-FEB-02 1KZV

TITLE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) TITLE 2 PEPTIDE IN CHLOROFORM METHANOL

COMPND MOL_ID: 1; COMPND 2 MOLECULE: VPR PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 34-51; COMPND 5 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT SOURCE 4 IS NATURALLY FOUND IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SOURCE 5 (NEW YORK-5 ISOLATE) (HIV-1).

KEYWDS HIV-1, VPR, PEPTIDE, SOLUTION STRUCTURE, CHLOROFORM, KEYWDS 2 METHANOL, NMR, VIRAL PROTEIN

EXPDTA SOLUTION NMR

NUMMDL 20

AUTHOR A.ENGLER,T.STANGLER,D.WILLBOLD

REVDAT 2 24-FEB-09 1KZV 1 VERSN REVDAT 1 28-AUG-02 1KZV 0

JRNL AUTH A.ENGLER,T.STANGLER,D.WILLBOLD JRNL TITL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 JRNL TITL 2 VPR(34-51) PEPTIDE IN MICELLE CONTAINING AQUEOUS JRNL TITL 3 SOLUTION. JRNL REF EUR.J.BIOCHEM. V. 269 3264 2002 JRNL REFN ISSN 0014-2956 JRNL PMID 12084067 JRNL DOI 10.1046/J.1432-1033.2002.03005.X

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE CALCULATED USING REMARK 3 FLOATING CHIRALITY.

REMARK 4 REMARK 4 1KZV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-02. REMARK 100 THE RCSB ID CODE IS RCSB015517.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM VPR(34-51); 50 % REMARK 210 METHANOL D3, 50 % CHLOROFORM D1 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR 3.851, VNMR 5.3, NDEE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, REMARK 210 STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES.

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 12 PRO A 35 157.81 -49.95 REMARK 500 13 PRO A 35 150.53 -49.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 36 0.29 SIDE_CHAIN REMARK 500 2 ARG A 36 0.20 SIDE_CHAIN REMARK 500 3 ARG A 36 0.25 SIDE_CHAIN REMARK 500 4 ARG A 36 0.29 SIDE_CHAIN REMARK 500 5 ARG A 36 0.13 SIDE_CHAIN REMARK 500 6 ARG A 36 0.23 SIDE_CHAIN REMARK 500 7 ARG A 36 0.28 SIDE_CHAIN REMARK 500 8 ARG A 36 0.28 SIDE_CHAIN REMARK 500 9 ARG A 36 0.23 SIDE_CHAIN REMARK 500 10 ARG A 36 0.25 SIDE_CHAIN REMARK 500 11 ARG A 36 0.32 SIDE_CHAIN REMARK 500 14 ARG A 36 0.32 SIDE_CHAIN REMARK 500 15 ARG A 36 0.28 SIDE_CHAIN REMARK 500 16 ARG A 36 0.20 SIDE_CHAIN REMARK 500 17 ARG A 36 0.27 SIDE_CHAIN REMARK 500 18 ARG A 36 0.30 SIDE_CHAIN REMARK 500 19 ARG A 36 0.31 SIDE_CHAIN REMARK 500 20 ARG A 36 0.22 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 52

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KZS RELATED DB: PDB REMARK 900 1KZS IS THE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE REMARK 900 1 VPR(34-51) PEPTIDE IN AQUEOUS TFE SOLUTION. REMARK 900 RELATED ID: 1KZT RELATED DB: PDB REMARK 900 1KZT IS THE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE REMARK 900 1 VPR(34-51) PEPTIDE IN DPC MICELLE CONTAINING AQUEOUS REMARK 900 SOLUTION.

DBREF 1KZV A 34 51 UNP P12520 VPR_HV1N5 34 51

SEQRES 1 A 20 ACE PHE PRO ARG ILE TRP LEU HIS ASN LEU GLY GLN HIS SEQRES 2 A 20 ILE TYR GLU THR TYR GLY NH2

HET ACE A 33 6 HET NH2 A 52 3

HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP

FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N

HELIX 1 1 ARG A 36 GLY A 51 1 16

LINK C ACE A 33 N PHE A 34 1555 1555 1.31 LINK C GLY A 51 N NH2 A 52 1555 1555 1.31

SITE 1 AC2 1 GLY A 51

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000